Provexis reduces losses
Sports nutrition company Provexis said it narrowed losses during the first half of its financial year and believes it is poised to make further progress.
Sports nutrition company Provexis said it narrowed losses during the first half of its financial year and believes it is poised to make further progress.
Underlying operating losses narrowed to £0.51m for the six months ended September 30th 2012 compared to a loss of £1.03m a year earlier. Revenues for the period increased to £3.26m from £1.53m previously.
Provexis, which develops, licenses and markets scientifically-proven functional food and sports nutrition technologies, said cash balance at the end of September was £1.4m compared to £2.8m in 2011.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Stephen Moon, Chief Executive Officer commented: "We are very pleased with the progress made with our Science in Sport business, which has continued to grow despite some very tough trading conditions across the sector, including the effect of the extremely poor weather in June and July."
"With broadened distribution, margin improvements feeding into increased marketing and sales investment, and a healthy innovation pipeline, we are confident of continued progress in the second half," he added.
Meanwhile Fruitflow continues to make progress, with nine regional consumer products now on the market around the globe and more to follow in the second half of the year, the group explained.
"With a commercially viable tablet grade format now complete, we have reached a major milestone, as this gives us access to the dietary supplement sector. We continue to work very closely with DSM on developing further consumer understanding of Fruitflow and in regulatory matters," Moon said.
Provexis said it is now seeing significantly reduced operating losses after its restructuring programme and it continues to seek further cost savings and efficiency improvements.
"The economic climate remains very challenging, but with our continued commitment to focusing on the twin revenue streams of SiS and Fruitflow, while managing costs carefully, we believe the business is well placed to make further progress."
CJ
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
What the Employment Rights Bill means for your workplace rights
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published